BMO Capital Markets

Stories

Freeport approves $4.5 billion expansion of Arizona copper mine

Forecasts a sixth consecutive molybdenum deficit in 2027

Freeport-McMoRan's board approved a $4.5 billion expansion of its Bagdad mine in northwest Arizona on November 4, 2026. The project would more than double mining and milling rates, lifting long-term copper output above 400 million pounds a year and molybdenum above 20 million pounds.

Updated 2 days ago

Acadia pushes Alzheimer's psychosis drug to phase 3 despite missed trial goal

New Capabilities

As of September 2026: Provider of analyst commentary on Acadia

Acadia Pharmaceuticals said its experimental Alzheimer's psychosis treatment missed the primary goal of a phase 2 trial. The company is advancing remlifanserin to phase 3 anyway, betting a refined study design can turn a near-miss into a win.

Updated Sep 24